A Novel Purine and Uric Metabolism Signature Predicting the Prognosis of Hepatocellular Carcinoma

被引:7
作者
Yang, Shengjie [1 ]
Zhang, Baoying [1 ]
Tan, Weijuan [1 ]
Qi, Lu [1 ]
Ma, Xiao [2 ]
Wang, Xinghe [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Phase 1 Clin Trial Ctr, Beijing, Peoples R China
[2] Zhangqiu Peoples Hosp, Dept Internal Med, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; prognosis; metabolism signature; purine; uric acid; PATHWAY; GENES; ACID;
D O I
10.3389/fgene.2022.942267
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Hepatocellular carcinoma (HCC) is regarded as one of the most common cancers in the world with a poor prognosis. Patients with HCC often have abnormal purine and uric acid metabolism, but their relationship with prognosis is unclear.Methods: Here, we collected the data of peripheral blood uric acid and clinical data in 50 patients with HCC and analyzed the relationship with prognosis. At the same time, the transcriptome sequencing data of TCGA and GEO databases were collected to analyze the changes in purine metabolic pathway activity and construct a prognosis prediction model. Based on the prognosis prediction model related to purine metabolism, we further looked for the differences in the immune microenvironment and molecular level and provided possible drug targets.Results: We found that the level of serum uric acid was positively correlated with the prognosis of HCC. At the same time, purine metabolism and purine biosynthesis pathway activities were significantly activated in patients with a poor prognosis of HCC. The prognosis prediction model of HCC based on purine metabolism and purine biosynthesis pathway can accurately evaluate the prognosis of patients with HCC. Meanwhile, we found that there were significant changes in tumor immune infiltration microenvironment and biological function at the molecular level in patients with over-activation of purine metabolism and purine biosynthesis pathway. In addition, we found that uric acid level was positively correlated with peripheral blood leukocytes in HCC patients.Conclusion: In this study, we found that the level of peripheral blood uric acid in patients with HCC is correlated with their prognosis. The prognosis of patients with HCC can be accurately predicted through the metabolic process of uric acid and purine.
引用
收藏
页数:10
相关论文
共 23 条
  • [1] Photodynamic and antiangiogenic activities of parietin liposomes in triple negative breast cancer
    Ayoub, Abdallah M.
    Amin, Muhammed U.
    Ambreen, Ghazala
    Abu Dayyih, Alice
    Abdelsalam, Ahmed M.
    Somaida, Ahmed
    Engelhardt, Konrad
    Wojcik, Matthias
    Schaefer, Jens
    Bakowsky, Udo
    [J]. BIOMATERIALS ADVANCES, 2022, 134
  • [2] Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma
    Dai, Kunfu
    Liu, Chao
    Guan, Ge
    Cai, Jinzhen
    Wu, Liqun
    [J]. BMC CANCER, 2022, 22 (01)
  • [3] Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer
    David, Stefan
    Kan, Takatsugu
    Cheng, Yulan
    Agarwal, Rachana
    Jin, Zhe
    Mori, Yuriko
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 378 (03) : 605 - 609
  • [4] Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer
    Gay, Martha D.
    Safronenka, Anita
    Cao, Hong
    Liu, Felice H.
    Malchiodi, Zoe X.
    Tucker, Robin D.
    Kroemer, Alexander
    Shivapurkar, Narayan
    Smith, Jill P.
    [J]. CANCER PREVENTION RESEARCH, 2021, 14 (01) : 17 - 29
  • [5] Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
    Kaemmerer, Daniel
    Schindler, Robin
    Mussbach, Franziska
    Dahmen, Uta
    Altendorf-Hofmann, Annelore
    Dirsch, Olaf
    Saenger, Joerg
    Schulz, Stefan
    Lupp, Amelie
    [J]. BMC CANCER, 2017, 17
  • [6] Individualized pathway activity algorithm identifies oncogenic pathways in pan-cancer analysis
    Ke, Xin
    Wu, Hao
    Chen, Yi-Xiao
    Guo, Yan
    Yao, Shi
    Guo, Ming-Rui
    Duan, Yuan-Yuan
    Wang, Nai-Ning
    Shi, Wei
    Wang, Chen
    Dong, Shan-Shan
    Kang, Huafeng
    Dai, Zhijun
    Yang, Tie-Lin
    [J]. EBIOMEDICINE, 2022, 79
  • [7] A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
    Kong, Weihao
    Mao, Zhongxiang
    Han, Chen
    Ding, Zhenxing
    Yuan, Qianqian
    Zhang, Gaosong
    Li, Chong
    Wu, Xuesheng
    Chen, Jia
    Guo, Manyu
    Hong, Shaocheng
    Yu, Feng
    Liu, Rongqiang
    Wang, Xingyu
    Zhang, Jianlin
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
    La Grotta, Rosalba
    de Candia, Paola
    Olivieri, Fabiola
    Matacchione, Giulia
    Giuliani, Angelica
    Rippo, Maria Rita
    Tagliabue, Elena
    Mancino, Monica
    Rispoli, Francesca
    Ferroni, Sabina
    Berra, Cesare Celeste
    Ceriello, Antonio
    Prattichizzo, Francesco
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (05)
  • [9] Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check
    Lee, Amy
    Lee, Fa-Chyi
    [J]. FRONTIERS OF MEDICINE, 2020, 14 (03) : 273 - 283
  • [10] The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma
    Murakami, Keigo
    Kumata, Hiroyuki
    Miyagi, Shigehito
    Kamei, Takashi
    Sasano, Hironobu
    [J]. PATHOLOGY INTERNATIONAL, 2021, 71 (10) : 682 - 691